Aehr Test Systems (AEHR)
NasdaqCM · Price as of · Nasdaq Real Time Price
- Profitability0/20
Losing money: $-7.1M net income over the last four reported quarters. Revenue over the last four reported quarters was $50.0M, down 17% from $59.9M the year before.
- Insider buying vs selling15/20
The last 20 Form 4s show no open-market buys or sells (grants and option exercises don't count either way). Neutral. Separately, 1 new 5%+ stake disclosure (13D/13G) hit in the last 6 months, which is big-money accumulation.
- Dilution and offerings6/15
Share count up 9.0% in a year plus 2 offering-related filings. Real dilution. One nuance: offerings raise cash that can fund real growth. The score docks the certain near-term dilution; if the spending pays off, it shows up later in the profitability component.
- Analysts5
- Implied upside+130.0%
- Target range$110.00 to $175.00
- EPS expected$0.13 +1167%
- A year ago$0.01
- Revenue expected$27.5M +151%
- Estimate range$0.12 to $0.13
AEHR closed at $63.88 on Oct 21, down 36.5% since Sep 22. Chart read: price below both the 50-day and 200-day moving averages; the 50-day is above the 200-day (uptrend structure); trading at 29% of the 52-week range ($19.40 to $145.61).
Insider buying and selling at Aehr Test Systems (AEHR)
The most recent Form 4 on record for Aehr Test Systems (AEHR) is August 12, 2026, when Gayn Erickson, President and CEO, sold $5.2M of stock. Nothing in the filing ties this one to a pre-arranged plan, so it was the filer's own call.
| Insider | Action | Value | Date | Type |
|---|---|---|---|---|
| Gayn Erickson · President and CEO | Sell | $5.2M | August 12, 2026 | Red flag |
| Geoffrey Gates Scott · Director | Sell | $2.6M | August 12, 2026 | Worth a look |
| Howard T Slayen · Director | Sell | $2.2M | August 4, 2026 | Worth a look |
| Alberto Salamone · EVP, PPBI BUSINESS | Sell | $2.8M | April 20, 2026 | Worth a look |
| Geoffrey Gates Scott · Director | Sell | $5.7M | April 21, 2026 | Worth a look |
Filed notices to sell
A Form 144 is filed beforean insider sells restricted stock. The Form 4 reporting the completed trade isn't due until two business days after the sale, so these land first. They are intentions, not transactions.
| Insider | Value | Filed | Status | Type |
|---|---|---|---|---|
| ROGERS VERNON · Officer | $574,217 | August 17, 2026 | Executed | Vested shares |
| POSEDEL RHEA J · Director | $836,220 | August 14, 2026 | Executed | Vested shares |
| ROGERS VERNON · Officer | $273,000 | August 14, 2026 | Not yet reported | Vested shares |
| SLAYEN HOWARD T · Director | $753,911 | August 14, 2026 | Executed | Own call |
| SALAMONE ALBERTO · Officer | $1.2M | August 13, 2026 | Executed | Vested shares |
SEC filings
| Form | Filed | Description |
|---|---|---|
| 4 | October 20, 2026 | PRIMARY DOCUMENT |
| 8-K | October 20, 2026 | FORM 8-K |
| 4 | October 13, 2026 | PRIMARY DOCUMENT |
| 4 | October 13, 2026 | PRIMARY DOCUMENT |
| 4 | October 13, 2026 | PRIMARY DOCUMENT |
| 4 | October 13, 2026 | PRIMARY DOCUMENT |
| 4 | October 13, 2026 | PRIMARY DOCUMENT |
| 4 | October 13, 2026 | PRIMARY DOCUMENT |
Aehr Test Systems news
All 14 articles
What each chip equipment stock actually sells, from ASML lithography to Aehr (AEHR) burn-in.
Seven listed companies sell the machines that make and check chips, and they are not one business. What each one does in a fab, why their growth rates diverge, and what the 2026 reporting cycle showed.
Aehr (AEHR) is up over 500% on the year, and five insiders just sold $11.15 million without a trading plan
On Aug. 12, five Aehr insiders including the CEO, the COO and the company's founder sold 85,130 shares for $11.15 million, and every one of them picked the date without a trading plan.
Aehr Test Systems (AEHR) director bought 20,000 shares at $15.50. He just filed to sell the same block near $109.
Fourteen insiders filed notices to sell stock on Tuesday. Thirteen were selling shares the company gave them. The fourteenth, a director at Aehr Test Systems, was selling 20,000 shares he bought himself at $15.50 two years ago.
Articles that mention Aehr Test Systems without it being the main subject.
AI stock battle week 10: Grok retakes the lead on the last day as five AIs gain (September 26, 2026)
Grok retook first place from DeepSeek on Friday as five of the six AI-run portfolios gained. Claude sold UiPath the same day Meta AI bought it, at the same price.
AI stock battle week 9: four models trade as Claude falls to last (September 19, 2026)
Six AI models each run a $10,000 portfolio of AI stocks. Four of them traded this Saturday and put $10,404.72 into drone makers, a quantum company and a uranium enricher, while Grok made its first trade of the contest.
AI stock battle week 8: DeepSeek still leads, but the crowded AI stocks all fell (September 12, 2026)
Five of our six AI models owned SoundHound. It closed lower in all four sessions. Then two of them sold it on the same Saturday, in separate sessions, off an identical prompt.
Frequently asked questions
When does AEHR report earnings?
Aehr Test Systems (AEHR) is scheduled to report quarterly results on November 2, 2026. The 3-analyst consensus is $0.13 per share on revenue of $27.5M for the quarter ended September 30, 2026, against $0.01 and $11.0M a year earlier.
What do analysts expect for AEHR?
5 analysts cover Aehr Test Systems (AEHR). The consensus rating is Strong buy. The average price target is $128.00, in a range of $110.00 to $175.00.
Are insiders buying or selling AEHR?
We track Form 4 filings for Aehr Test Systems (AEHR). The activity listed on this page shows 5 qualifying sales. Each row is labelled Routine when the filer declared a pre-arranged 10b5-1 plan, Tax withholding when shares were sold automatically to cover the tax on a vest, or Own call when neither applies.
Where can I see AEHR SEC filings?
Recent filings are listed on this page, newest first. The latest is a 4 filed October 20, 2026.